On the afternoon of June 10th, the Shengyuan Pharmaceutical 2025 Dealer Cooperation Negotiation Conference with the theme of "Riding on the Trend, Working Together to Achieve Far" was grandly launched. The conference focuses on the core strategy of taurine's full life cycle health field. Representatives of distributors in the four major regions of Fujian, Guangxi, Chongqing, and Sichuan have signed a heavyweight contract with Shengyuan Pharmaceutical, marking the full launch of a deep cooperation network for taurine health products covering key markets across the country.
Shengyuan Environmental Protection Chairman Zhu Yuxiuan, Deputy General Manager Chen Wenyu, Technical Director Wang Tiejun, Deputy General Manager of Marketing Zhu Zhuowei, Brand Director Shi Qiaochao, Office Administrative Director Lin Yanxing, and others attended the event to jointly look forward to the broad prospects of the taurine health track with distributors from all over the country.
At the conference, several distributor representatives shared their real experiences and market confidence in the taurine series products, demonstrating a high recognition of the market value of core products such as Shengyuan Tree Western Ginseng Taurine Oral Liquid, Yuanqi Xiaoshu Taurine Energy Drink, and Yuanqi Xiaoshu Taurine L-carnitine Sports Nutritional Beverage.
Dealer representative speaks
Chairman Zhu Yuxiuan made a concluding speech, elaborating on the company's core strategy and win-win vision of deepening the taurine health track.
Chairman Zhu Yuxiuan stated that Shengyuan Pharmaceutical has always focused on exploring and applying the core value of taurine in human life cycle health, and is committed to creating a scientific and accurate taurine full range of health solutions. Distributor partners are the core co builders of Shengyuan Pharmaceutical's taurine ecosystem. The company will continue to provide partners with a comprehensive range of taurine products with strong market competitiveness, covering "from basic nutritional support to functional health interventions". Through more accurate brand marketing, more professional terminal sales empowerment (such as linkage with comprehensive health activities, sports events, and community health promotion), and more flexible regional policies, the company will comprehensively enhance partners' market development and service capabilities, and share the benefits of the booming taurine health industry.
The successful signing of contracts in the four major regions across the country is a strong recognition from the market for Shengyuan Pharmaceutical's deep cultivation in the field of taurine and its professional ability to create full lifecycle health products. The extensive geographical coverage and core channels covered by the agreement have built a solid network foundation for the company to achieve its annual goal of "reaching a wider audience with high-quality taurine health products". Authoritative data shows that the global taurine application market is expanding at an average annual compound growth rate of over 8%. As a major producer of taurine and with vast market consumption potential, China has broad development prospects for taurine based health products. The product matrix of Shengyuan Pharmaceutical covers multiple scenarios including daily health care (oral liquids), instant energy (energy drinks), and professional sports (sports drinks), entering the segmented track to meet the refined and scenario based needs of the market's health consumption.
Dealer on-site signing
This negotiation meeting takes strategic signing as a new starting point. Against the backdrop of the continuous improvement of national health awareness and the explosive demand for precision nutrition, Shengyuan Pharmaceutical is working together with its distributor partners across the country to build a health service network covering multiple consumer scenarios, relying on its taurine full category scientific product matrix. The results of this negotiation will not only inject strong momentum into the market expansion of Shengyuan Pharmaceutical in the new year, but also further promote the high-quality development of China's taurine application industry.
